Ftse Mib
32.665,21
-2,81%
DAX
18.002,02
-1,43%
S&P 500
5.431,60
-0,04%
NASDAQ
17.688,88
0,12%
Bitcoin
66.176,83
0,26%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Capstone Therapeutics Corp (MM) (CAPS) Capstone Therapeutics Corp (MM) (CAPS) Notizie

CAPS

Capstone Therapeutics Corp (MM) (CAPS)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CAPS
DataOraFonteTitoloSimboloCompagnia
07/05/201815:00GlobeNewswire Inc.LipimetiX Development Announces Sub-License of Apo E Mimetic Peptide Platform to Anji Pharma, ChinaNASDAQ:CAPSCapstone Therapeutics Corp (MM)
20/07/201112:03Edgar (US Regulatory)Current report filing (8-K)NASDAQ:CAPSCapstone Therapeutics Corp (MM)
19/07/201100:12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CAPSCapstone Therapeutics Corp (MM)
06/07/201114:00GlobeNewswire Inc.Capstone Therapeutics Announces Pre-Clinical Results With AZX100 in Radiation and Bleomycin Models of Pulmonary Fibrosis; PulmonNASDAQ:CAPSCapstone Therapeutics Corp (MM)
09/06/201119:21Edgar (US Regulatory)Amended Securities Registration (section 12(b)) (8-A12B/A)NASDAQ:CAPSCapstone Therapeutics Corp (MM)
08/06/201118:31Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (DEFA14A)NASDAQ:CAPSCapstone Therapeutics Corp (MM)
08/06/201118:30GlobeNewswire Inc.Capstone Therapeutics Announces Adjournment of Its Annual Meeting of Stockholders and Intention to Reconvene the Meeting on JuneNASDAQ:CAPSCapstone Therapeutics Corp (MM)
31/05/201120:00GlobeNewswire Inc.Capstone Therapeutics Signs Alliance With BiolineRx to Develop Chrysalin (TP508) in Acute Myocardial InfarctionNASDAQ:CAPSCapstone Therapeutics Corp (MM)
26/05/201123:00GlobeNewswire Inc.Capstone Therapeutics Reminds Stockholders of Annual Meeting on June 6, 2011 and Encourages All Stockholders to VoteNASDAQ:CAPSCapstone Therapeutics Corp (MM)
13/05/201115:00Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:CAPSCapstone Therapeutics Corp (MM)
29/04/201121:12Edgar (US Regulatory)Proxy Statement (definitive) (DEF 14A)NASDAQ:CAPSCapstone Therapeutics Corp (MM)
27/04/201122:45GlobeNewswire Inc.Capstone Therapeutics Confirms Early Signal of AZX100 Effect Based on Final Results of Phase 2a Pilot Clinical Trial in SurgicalNASDAQ:CAPSCapstone Therapeutics Corp (MM)
04/04/201122:05GlobeNewswire Inc.Capstone Therapeutics Announces Update to Timing of Release of Final Results From AZX100 Phase 2a Pilot Clinical Trial in SurgicNASDAQ:CAPSCapstone Therapeutics Corp (MM)
29/03/201115:02Edgar (US Regulatory)Annual Report (10-K)NASDAQ:CAPSCapstone Therapeutics Corp (MM)
11/02/201119:11Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:CAPSCapstone Therapeutics Corp (MM)
06/01/201122:52GlobeNewswire Inc.Capstone Therapeutics to Present at Biotech Showcase 2011NASDAQ:CAPSCapstone Therapeutics Corp (MM)
14/12/201003:18GlobeNewswire Inc.Capstone Therapeutics Announces Results of AZX100 Phase 2a Pilot Clinical Trials in Keloid and Surgical ScarringNASDAQ:CAPSCapstone Therapeutics Corp (MM)
08/12/201023:00GlobeNewswire Inc.Capstone Therapeutics to Host AZX100 Clinical Update TeleconferenceNASDAQ:CAPSCapstone Therapeutics Corp (MM)
10/11/201012:00GlobeNewswire Inc.Capstone Therapeutics Announces Third Quarter 2010 Financial ResultsNASDAQ:CAPSCapstone Therapeutics Corp (MM)
03/11/201014:00GlobeNewswire Inc.Capstone Therapeutics to Host Quarterly Update Conference CallNASDAQ:CAPSCapstone Therapeutics Corp (MM)
02/10/201001:45GlobeNewswire Inc.Capstone Therapeutics to Present at 9th Annual BIO Investor ForumNASDAQ:CAPSCapstone Therapeutics Corp (MM)
13/09/201019:00GlobeNewswire Inc.Capstone Therapeutics Announces Progress in Clinical Trials of AZX100 in Keloid ScarringNASDAQ:CAPSCapstone Therapeutics Corp (MM)
07/09/201019:00GlobeNewswire Inc.Capstone Therapeutics to Present at Rodman & Renshaw 12th Annual Healthcare ConferenceNASDAQ:CAPSCapstone Therapeutics Corp (MM)
09/08/201013:00GlobeNewswire Inc.Capstone Therapeutics Announces Second Quarter 2010 Financial ResultsNASDAQ:CAPSCapstone Therapeutics Corp (MM)
06/07/201014:00GlobeNewswire Inc.Capstone Therapeutics Announces Continuation of AZX100 Phase 2 Clinical Trial in Dermal Scarring Following Shoulder SurgeryNASDAQ:CAPSCapstone Therapeutics Corp (MM)
25/05/201022:17Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CAPSCapstone Therapeutics Corp (MM)
24/05/201013:00GlobeNewswire Inc.Capstone Therapeutics Corp. Appoints Robert J. Spiegel, MD to Board of DirectorsNASDAQ:CAPSCapstone Therapeutics Corp (MM)
21/05/201019:07GlobeNewswire Inc.Capstone Therapeutics Corp. Announces Stockholder Approval of "Put Right" and Name Change; Management to Host Conference CallNASDAQ:CAPSCapstone Therapeutics Corp (MM)
14/05/201020:00GlobeNewswire Inc.Capstone Therapeutics to Present at Rodman & Renshaw 6th Annual Global Healthcare ConferenceNASDAQ:CAPSCapstone Therapeutics Corp (MM)
12/05/201013:00GlobeNewswire Inc.Capstone Therapeutics Announces Continuation of Second of Two AZX100 Phase 2 Clinical Trials in Keloid ScarringNASDAQ:CAPSCapstone Therapeutics Corp (MM)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CAPS

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
STLAM
Stellantis NV
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
ENEL
Enel
BIT
ENI
Eni
BIT
BPE
Bper Banca
BIT
LDO
Leonardo
BIT
STMMI
ST Microelectronics
BIT
BAMI
Banco BPM
BIT
RACE
Ferrari NV
BIT
SPM
Saipem
BIT
G
Generali
BIT
NEXI
Nexi S.p.A
BIT
TIT
Telecom Italia
BIT
PST
Poste Italiane S.p.a
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network